名稱 | BCR-ABL1 T315M/BaF3 |
型號(hào) | CBP73322 |
報(bào)價(jià) | ![]() |
特點(diǎn) | BCR-ABL1 [T315M]/BaF3 |
產(chǎn)品搜索
相關(guān)文章
- Z常用細(xì)胞系之top 5!
- 細(xì)胞株培養(yǎng)對(duì)于培養(yǎng)液的要求及相關(guān)常識(shí)說明
- HRD檢測之我見---科佰生物
- 4-1BB(CD137)靶點(diǎn)藥物篩選模型
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 【基因編輯產(chǎn)品新品上市】MET Ex14 skipping新添成員
- 從諾輝財(cái)報(bào)看甲基化市場,科佰生物助力甲基化標(biāo)準(zhǔn)品的開發(fā)
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 靶向claudin18.2藥物細(xì)胞篩選模型
- 泛腫瘤大panel質(zhì)控品升級(jí),免費(fèi)試用申請中
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73322BCR-ABL1 T315M/BaF3

- 詳細(xì)內(nèi)容
CBP73322 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [T315M]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1.WB of BCR-ABL1 [T315M]/BaF3 | |
2.Sanger of BCR-ABL1 [T315M]/BaF3 Figure 2. BCR-ABL1 [T315M]/BaF3
Figure 3. BCR-ABL1 [T315M]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 T315M Cells (C4). | |